Skip to content
Aperlena
Free alerts
Log in

Spain - Pharmaceutical products - Supply of Apalutamide (DOE), Paliperidone (DOE), Etravirine (DOE), Daratumumab (DOE), Ibrutinib (DOE), Guselkumab (DOE), Darunavir/Cobicistat combination (DOE), Selexipag (DOE), Lazertinib (DOE) and Amivantamab (DOE)

Original España - Productos farmacéuticos - Suministro de Apalutamida(DOE), Paliperidona(DOE),Etravirina(DOE),Daratumumab(DOE),Ibrutinib(DOE),Guselkumab(DOE),Asociación Darunavir/Cobicistat(DOE),Selexipag(DOE),Lazertinib(DOE) Y Amivantamab(DOE)

Awarded Contract award

Key facts

Winner
JANSSEN CILAG, S.A.
Awarded value
€167,923,601
Estimated value
€201,508,321
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Where
Spain País Vasco
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 3 weeks ago
Notice number
598628-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

Osakidetza, the Basque Health Service (Central Organisation), awarded a contract for the supply of ten medicines: Apalutamide, Paliperidone, Etravirine, Daratumumab, Ibrutinib, Guselkumab, the Darunavir/Cobicistat combination, Selexipag, Lazertinib and Amivantamab, all under a dynamic procurement system (DOE). The contract was awarded to JANSSEN CILAG, S.A. for EUR 167,923,600.60. The awarded price is 17% below the estimated value of EUR 201,508,320.72.

Description

Suministro de Apalutamida(DOE), Paliperidona(DOE),Etravirina(DOE),Daratumumab(DOE),Ibrutinib(DOE),Guselkumab(DOE),Asociación Darunavir/Cobicistat(DOE),Selexipag(DOE),Lazertinib(DOE) Y Amivantamab(DOE) L1_APALUTAMIDA (DOE); L2_PALIPERIDONA (DOE); L3_ETRAVIRINA (DOE); L4_DARATUMUMAB (DOE); L5_IBRUTINIB (DOE); L6_GUSELKUMAB (DOE); L7_ASOCIACIÓN DARUNAVIR/COBICISTAT (DOE); L8_SELEXIPAG (DOE); L9_LAZERTINIB (DOE); L10_AMIVANTAMAB (DOE)

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago

View the official notice

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,020,608
9,792 open across Europe right now
Buyer track record on Aperlena
556 notices tracked · 154 awarded
€1,978,170,865 in awarded contracts

Never miss a tender like this

756 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector